C1 esterase inhibitor-mediated immunosuppression in COVID-19: Friend or foe? [0.03%]
COVID-19中C1酯酶抑制剂介导的免疫抑制：朋友还是敌人？
Melissa A Hausburg,Jason S Williams,Kaysie L Banton et al.
Melissa A Hausburg et al.
From asymptomatic to severe, SARS-CoV-2, causative agent of COVID-19, elicits varying disease severities. Moreover, understanding innate and adaptive immune responses to SARS-CoV-2 is imperative since variants such as Omicron negatively imp...
SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in Austria [0.03%]
奥地利接种疫苗和感染恢复人群的SARS-CoV-2抗体测定
Elisabeth Mara,Tobias Mader,Johannes Gratzer et al.
Elisabeth Mara et al.
Since December 2019 the world has been dealing with a severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) pandemic. The first SARS-CoV-2 vaccine was made available in Europe at the end of 2020. 202 volunteers from the vicinity...
Syed Shahzad Hasan,Abdur Rashid,Sundus Osama et al.
Syed Shahzad Hasan et al.
Covid immunization commenced on 2nd Feb 2021 in Pakistan and as of 7th Sep 2021, over 84 million vaccine doses were administered in Pakistan, of which 72% procured by the government, 22% received through Covax and 6% were donated. The vacci...
Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review [0.03%]
接受抗COVID-19单克隆抗体治疗的患者对SARS-CoV-2的内源性抗体反应：一项系统综述
Andrea Lombardi,Cecilia Azzarà,Giulia Renisi et al.
Andrea Lombardi et al.
Passive immunization with mAbs has been employed in COVID-19. We performed a systematic review of the literature assessing the endogenous humoral immune response against SARS-CoV-2 in patients treated with mAbs. Administration of mAbs in se...
Memory T cell responses in seronegative older adults following SARS-CoV-2 vaccination [0.03%]
血清阴性老年个体接种新型冠状病毒疫苗后的记忆T细胞反应
Merve Hafızoğlu,Arzu Okyar Bas,Ece Tavukçuoğlu et al.
Merve Hafızoğlu et al.
Generating memory T cell responses besides humoral immune responses is essential when it comes to the efficacy of a vaccine. In this study, the presence of memory T cell responses after aluminum-adjuvanted inactivated whole-virion SARS-CoV-...
Khouloud Ferchichi,Imen Aouinti,Ahmed Zaiem et al.
Khouloud Ferchichi et al.
Introduction: Myocarditis is an adverse reaction discovered after the marketing of SARS-CoV-2 mRNA vaccines. Nevertheless, this effect is not mentioned as an adverse reaction in the summary of product characteristics of o...
Differential peripheral blood mononuclear cell reactivity against SARS-CoV-2 proteins in naïve and previously infected subjects following COVID-19 vaccination [0.03%]
新冠疫苗接种后先前感染者和未感染者外周血单个核细胞对SARS-CoV-2蛋白的反应性差异
Elizabete Cristina Iseke Bispo,Amandda Évelin Silva-Carvalho,Marielly Reis Resende Sousa et al.
Elizabete Cristina Iseke Bispo et al.
The decline in vaccine efficacy and the risk of reinfection by SARS-CoV-2 make new studies important to better characterize the immune response against the virus and its components. Here, we investigated the pattern of activation of T-cells...
Evaluation of the performance of a lateral flow device for quantitative detection of anti-SARS-CoV-2 IgG [0.03%]
评估用于定性检测抗SARS-CoV-2 IgG的侧向流动装置性能
J S Moore,L J Robertson,R Price et al.
J S Moore et al.
Introduction: The AbC-19™ lateral flow immunoassay (LFIA) performance was evaluated on plasma samples from a SARS-CoV-2 vaccination cohort, WHO international standards for anti-SARS-CoV-2 IgG (human), individuals ≥2 wee...
Disseminated tuberculosis, CMV viraemia & haemophagocytic-lymphohistiocystosis syndrome in an adult patient with anti- IFNγ autoantibodies - case report and brief review [0.03%]
成年抗干扰素γ自身抗体阳性患者的播散性结核、CMV血症及噬血细胞淋巴组织细胞综合征1例及相关文献综述
G I Butel-Simoes,C Kiss,K Kong et al.
G I Butel-Simoes et al.
We report a case of an adult female with disseminated tuberculosis, cytomegalovirus viraemia and haemophagocytic-lymphohistiocystosis syndrome associated with neutralizing anti- interferon gamma (IFNγ) autoantibodies demonstrated by absent...